METHYL BROMIDE RISK CHARACTERIZATION IN CALIFORNIA

Author： Wedge Roberta M.   Abt Eileen N.   Hobbs Charles H.  

Publisher： Taylor & Francis Ltd

ISSN： 1521-6950

Source： Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol.4, Iss.3, 2001-07, pp. : 333-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Manufacture, Characterization, and Pharmacodynamic Evaluation of Engineered Ipratropium Bromide Particles

By Taylor Michael   Hickey Anthony   VanOort Michiel  

Pharmaceutical Development and Technology, Vol. 11, Iss. 3, 2006-09 ,pp. : 321-336

Informa Healthcare

Access to resources Recommend Favorite

RISK CHARACTERIZATION: PRINCIPLES AND PRACTICE

By Williams Pamela R. D.   Paustenbach Dennis J.  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 5, Iss. 4, 2002-10 ,pp. : 337-406

Taylor & Francis Ltd

Access to resources Recommend Favorite

Summary of the Risk Characterization Papers

By Vincent B.F.  

Regulatory Toxicology and Pharmacology, Vol. 26, Iss. 1, 1997-08 ,pp. : 69-69

Academic Press

Access to resources Recommend Favorite

Characterization and Antioxidant Activity of Quercetin/Methyl-β-Cyclodextrin Complexes

By  

Current Drug Delivery, Vol. 13, Iss. 3, 2016-05 ,pp. : 444-451

Bentham Science Publishers

Access to resources Recommend Favorite

A RISK CHARACTERIZATION FOR ATRAZINE: ONCOGENICITY PROFILE

By Stevens James T.   Breckenridge Charles B.   Wetzel Larry   Thakur Ajit K.   Liu Cynthia   Werner Christoph   Luempert Louis G.   Eldridge J. Charles  

Journal of Toxicology and Environmental Health, Vol. 56, Iss. 2, 1999-01 ,pp. : 69-109

Taylor & Francis Ltd

Access to resources Recommend Favorite